Stratasys (SSYS) director Crump details shares, RSUs and option grants
Rhea-AI Filing Summary
STRATASYS LTD. director S. Scott Crump filed an initial ownership report showing a mix of ordinary shares, restricted share units, and stock options. He directly holds 220,155 ordinary shares and an additional 6,113 ordinary shares underlying RSUs that began vesting on November 23, 2025 and will fully vest by November 23, 2026.
Crump also indirectly holds 176,294 ordinary shares through his spouse. His derivative position includes several option grants over ordinary shares, such as 100,000 underlying shares at an exercise price of $19.9600 expiring on April 6, 2027, and additional smaller option blocks expiring between 2031 and 2035. One option grant dated September 30, 2025 vests in 12 equal monthly installments over the same November 23, 2025–November 23, 2026 schedule.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
Footnotes (1)
- The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person on September 30, 2025 and that vest and settle for underlying ordinary shares in 12 equal monthly installments over a vesting period that commenced on November 23, 2025 and will conclude on the one-year anniversary of the vesting commencement date (November 23, 2026), by which time all such RSUs will be fully vested (and underlying shares issued). The options reported in this row were granted to the Reporting Person by the Issuer on September 30, 2025 and vest and become exercisable in 12 equal monthly installments over a vesting period that commenced on November 23, 2025 and will conclude on the one-year anniversary of the vesting commencement date (November 23, 2026), by which time all such options will be fully vested and exercisable.